SEEKING BUYER
Houston Neurology Platform | $3.5M Revenue | $2.1M EBITDA
Healthcare · Houston, TX, USA
revenue: $3,500,000
ebitda: $2,100,000
Exclusivity:
Exclusive Representation
SBA Eligiblity:
Eligible
Revenue:
$3,500,000
EBITDA:
$2,100,000
Practice Capital is advising on the sale of a Texas neurology and pain management platform generating approximately $3.5M in annual revenue and $2.1M in EBITDA. The platform combines a clinical practice with an in-house neurodiagnostic testing center offering EEG, EMG and nerve conduction studies. Services include neurology, pain medicine and traumatic brain injury care, including personal injury (PI) patients. It operates a cash-pay and out-of-network model, with approximately 20% of revenue derived from medical-legal services, including independent medical examinations and expert testimony. The owner plans to retire in three years and is seeking a partner to scale the platform to multiple locations before his retirement. Please review the attached teaser and contact me for further information. Financials and data-room access are available following execution of an NDA. Andrew Borg Costanzi Managing Director Practice Capital (redacted